Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Julia Bohlius, Heinz Haverkamp, Volker Diehl, Houchingue Eghbali, Christopher Ferme, Jeremy Franklin, Beate Pfistner, Petra Schiller, John Raemaekers, Andreas Engert, Michel Henry-Amar

Blood (2006) 108 (11): 2473.

https://doi.org/10.1182/blood.V108.11.2473.2473

Published: 2006

Journal Articles

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Julia Bohlius, MD, MScPH, Heinz Haverkamp, MSc, Volker Diehl, MD, Houchingue Eghbali, MD, Jeremy Franklin, MSc, Beate Pfistner, MSc, John Raemaekers, MD, PhD, Andreas Engert, MD, Michel Henry-Amar, MD, PhD

Blood (2005) 106 (11): 5577.

https://doi.org/10.1182/blood.V106.11.5577.5577

Published: 2005

Journal Articles

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Christophe Ferme, MD, Marine Diviné, MD, Andrej Vranovsky, MD, Frank Morschhauser, MD, Réda Bouabdallah, MD, Jean Gabarre, MD, Aspasia Bastard-Stamatoullas, MD, Richard Delarue, MD, Vittorina Zagonel, MD, Jérôme Jaubert, MD, Anton Hagenbeek, MD, Mark Henri H. Kramer, MD, Chantal Rieux, José Thomas, MD, Michel Henry-Amar, MD

Blood (2005) 106 (11): 813.

https://doi.org/10.1182/blood.V106.11.813.813

Published: 2005

Journal Articles

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Houchingue Eghbali, MD, Pauline Brice, MD, Geert-Yan Creemers, MD, Marinus van Marwijk Kooij, MD, Patrice Carde, MD, Mars B. Van’t Veer, MD, Elli Lugtenburg, MD, Anne Sonet, MD, Catherine Sebban, MD, Michel Blanc, MD, John M. Raemaekers, MD, Laurent Voillat, MD, Chantal Rieux, Ed M. Noordijk, MD, Michel Henry-Amar, MD

Blood (2005) 106 (11): 814.

https://doi.org/10.1182/blood.V106.11.814.814

Published: 2005

Journal Articles

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Marc André, Nicolas Mounier, Xavier Leleu, Anne Sonet, Pauline Brice, Michel Henry-Amar, Hervé Tilly, Bertrand Coiffier, André Bosly, Pierre Morel, Corinne Haioun, Philippe Gaulard, Felix Reyes, Christian Gisselbrecht, the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Blood (2004) 103 (4): 1222–1228.

https://doi.org/10.1182/blood-2003-04-1124

Published: 2004

Journal Articles

Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin’s Disease

Marc André, Michel Henry-Amar, Didier Blaise, Philippe Colombat, Joël Fleury, Noël Milpied, Jean-Yves Cahn, José-Luis Pico, Yves Bastion, Mathieu Kuentz, Gérard Nedellec, Michel Attal, Christophe Fermé, Christian Gisselbrecht

Blood (1998) 92 (6): 1933–1940.

https://doi.org/10.1182/blood.V92.6.1933

Published: 1998

NARROW

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin’s Disease

Email alerts

ASH Publications

American Society of Hematology

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin’s Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only